GlassScriptPhysician profile
Daniel S Hoyt
NPI 1366403800
$2,302.53
in general payments reported to CMS, 2019-2025
14 companies · $80.04 in 2025
The $80.04 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $30.66 · 2021: $1,437 · 2022: $123 · 2023: $83.85 · 2024: $162 · 2025: $80.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,464.32 | 2021-2024 | Bulkamid |
| Boston Scientific Corporation | $268.38 | 2019-2024 | Ams 700 Cxr Rte Kit, Ams 700 |
| Medtronic, INC. | $196.39 | 2021-2025 | Interstim, Truclear |
| Neotract INC. | $102.84 | 2019 | |
| Medtronic USA, INC. | $66.97 | 2019-2020 | |
| Caldera Medical, INC | $40.83 | 2022 | |
| Photocure INC | $34.16 | 2019 | |
| Astellas Pharma US INC | $23.33 | 2019 | |
| Karl Storz Endoscopy-America | $22.79 | 2019 | |
| Dentsply Ih INC. | $19.51 | 2019 | |
| Ethicon US, LLC | $17.70 | 2025 | Prolene, Vicryl, Monocryl |
| Endo Pharmaceuticals INC. | $16.50 | 2023 | Xiaflex |
| Ferring Pharmaceuticals INC. | $16.41 | 2025 | Adstiladrin |
| Coloplast Corp | $12.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoyt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.